Cargando…

T(FH)2 cells associate with enhanced humoral immunity to SARS‐CoV‐2 inactivated vaccine in patients with allergic rhinitis

Detalles Bibliográficos
Autores principales: Yao, Yin, Wang, Zhe‐Zheng, Huang, Ao, Liu, Yan, Wang, Nan, Wang, Zhi‐Chao, Yang, Lin, Li, Hui‐Jun, Xie, Jun‐Gang, Zhu, Rong‐Fei, Cheng, Li‐Ming, Yu, Di, Liu, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792397/
https://www.ncbi.nlm.nih.gov/pubmed/35083875
http://dx.doi.org/10.1002/ctm2.717
_version_ 1784640352765870080
author Yao, Yin
Wang, Zhe‐Zheng
Huang, Ao
Liu, Yan
Wang, Nan
Wang, Zhi‐Chao
Yang, Lin
Li, Hui‐Jun
Xie, Jun‐Gang
Zhu, Rong‐Fei
Cheng, Li‐Ming
Yu, Di
Liu, Zheng
author_facet Yao, Yin
Wang, Zhe‐Zheng
Huang, Ao
Liu, Yan
Wang, Nan
Wang, Zhi‐Chao
Yang, Lin
Li, Hui‐Jun
Xie, Jun‐Gang
Zhu, Rong‐Fei
Cheng, Li‐Ming
Yu, Di
Liu, Zheng
author_sort Yao, Yin
collection PubMed
description
format Online
Article
Text
id pubmed-8792397
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-87923972022-02-04 T(FH)2 cells associate with enhanced humoral immunity to SARS‐CoV‐2 inactivated vaccine in patients with allergic rhinitis Yao, Yin Wang, Zhe‐Zheng Huang, Ao Liu, Yan Wang, Nan Wang, Zhi‐Chao Yang, Lin Li, Hui‐Jun Xie, Jun‐Gang Zhu, Rong‐Fei Cheng, Li‐Ming Yu, Di Liu, Zheng Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2022-01-26 /pmc/articles/PMC8792397/ /pubmed/35083875 http://dx.doi.org/10.1002/ctm2.717 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to Editor
Yao, Yin
Wang, Zhe‐Zheng
Huang, Ao
Liu, Yan
Wang, Nan
Wang, Zhi‐Chao
Yang, Lin
Li, Hui‐Jun
Xie, Jun‐Gang
Zhu, Rong‐Fei
Cheng, Li‐Ming
Yu, Di
Liu, Zheng
T(FH)2 cells associate with enhanced humoral immunity to SARS‐CoV‐2 inactivated vaccine in patients with allergic rhinitis
title T(FH)2 cells associate with enhanced humoral immunity to SARS‐CoV‐2 inactivated vaccine in patients with allergic rhinitis
title_full T(FH)2 cells associate with enhanced humoral immunity to SARS‐CoV‐2 inactivated vaccine in patients with allergic rhinitis
title_fullStr T(FH)2 cells associate with enhanced humoral immunity to SARS‐CoV‐2 inactivated vaccine in patients with allergic rhinitis
title_full_unstemmed T(FH)2 cells associate with enhanced humoral immunity to SARS‐CoV‐2 inactivated vaccine in patients with allergic rhinitis
title_short T(FH)2 cells associate with enhanced humoral immunity to SARS‐CoV‐2 inactivated vaccine in patients with allergic rhinitis
title_sort t(fh)2 cells associate with enhanced humoral immunity to sars‐cov‐2 inactivated vaccine in patients with allergic rhinitis
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792397/
https://www.ncbi.nlm.nih.gov/pubmed/35083875
http://dx.doi.org/10.1002/ctm2.717
work_keys_str_mv AT yaoyin tfh2cellsassociatewithenhancedhumoralimmunitytosarscov2inactivatedvaccineinpatientswithallergicrhinitis
AT wangzhezheng tfh2cellsassociatewithenhancedhumoralimmunitytosarscov2inactivatedvaccineinpatientswithallergicrhinitis
AT huangao tfh2cellsassociatewithenhancedhumoralimmunitytosarscov2inactivatedvaccineinpatientswithallergicrhinitis
AT liuyan tfh2cellsassociatewithenhancedhumoralimmunitytosarscov2inactivatedvaccineinpatientswithallergicrhinitis
AT wangnan tfh2cellsassociatewithenhancedhumoralimmunitytosarscov2inactivatedvaccineinpatientswithallergicrhinitis
AT wangzhichao tfh2cellsassociatewithenhancedhumoralimmunitytosarscov2inactivatedvaccineinpatientswithallergicrhinitis
AT yanglin tfh2cellsassociatewithenhancedhumoralimmunitytosarscov2inactivatedvaccineinpatientswithallergicrhinitis
AT lihuijun tfh2cellsassociatewithenhancedhumoralimmunitytosarscov2inactivatedvaccineinpatientswithallergicrhinitis
AT xiejungang tfh2cellsassociatewithenhancedhumoralimmunitytosarscov2inactivatedvaccineinpatientswithallergicrhinitis
AT zhurongfei tfh2cellsassociatewithenhancedhumoralimmunitytosarscov2inactivatedvaccineinpatientswithallergicrhinitis
AT chengliming tfh2cellsassociatewithenhancedhumoralimmunitytosarscov2inactivatedvaccineinpatientswithallergicrhinitis
AT yudi tfh2cellsassociatewithenhancedhumoralimmunitytosarscov2inactivatedvaccineinpatientswithallergicrhinitis
AT liuzheng tfh2cellsassociatewithenhancedhumoralimmunitytosarscov2inactivatedvaccineinpatientswithallergicrhinitis